Work

A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget's disease

Year: 2006

Type: conference-paper

Source: Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))

Authors: J Brown, Kenneth W. Lyles, William Fraser, Ian R. Reid, D. Hosking, Jean‐Pierre Devogelaer, C. Moniz, M. Hooper, Y. Saïdi, Grace L. Su, Jong Phill Pak, Jaclyn Davis, T. Fashola, Joel Krasnow, K. Zelenakas, P. Miller

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242963889

FWCI:

Cites:

Cited by:

Related to: 10